Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

REPCF REPLICEL LIFE SCIENCES INC

0.0770.0000.00%
Close 10/06 16:00 ET
High
0.000
Open
0.077
Turnover
0.00
Low
0.000
Pre Close
0.077
Volume
0.00
Market Cap
3.27M
P/E(TTM)
Loss
52wk High
0.320
Shares
42.75M
P/E(Static)
Loss
52wk Low
0.056
Float Cap
1.87M
Bid/Ask %
0.00%
Historical High
0.354
Shs Float
24.35M
Volume Ratio
0.00
Historical Low
0.056
Dividend TTM
--
Div Yield TTM
--
P/B
-0.58
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Float Cap
1.87M
Bid/Ask %
0.00%
Historical High
0.354
Shs Float
24.35M
Volume Ratio
0.00
Historical Low
0.056
Dividend TTM
--
P/B
-0.58
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in the development of autologous cell therapies that treat functional cellular deficits including chronic tendon injuries, androgenetic alopeci, and skin aging. Its products includes RCT-01, RCS-01, and RCH-01. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
CEO: Mr. R. Lee Buckler
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...